nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE5A—penis—Crohn's disease	0.0708	0.253	CbGeAlD
Pentoxifylline—NT5E—epithelium—Crohn's disease	0.0192	0.0685	CbGeAlD
Pentoxifylline—NT5E—smooth muscle tissue—Crohn's disease	0.0185	0.066	CbGeAlD
Pentoxifylline—NT5E—skin of body—Crohn's disease	0.0182	0.0651	CbGeAlD
Pentoxifylline—NT5E—mammalian vulva—Crohn's disease	0.0166	0.0594	CbGeAlD
Pentoxifylline—ADORA2B—smooth muscle tissue—Crohn's disease	0.0158	0.0565	CbGeAlD
Pentoxifylline—NT5E—lymphoid tissue—Crohn's disease	0.0148	0.0527	CbGeAlD
Pentoxifylline—ADORA2B—mammalian vulva—Crohn's disease	0.0142	0.0508	CbGeAlD
Pentoxifylline—Cholestasis—Mercaptopurine—Crohn's disease	0.0142	0.0293	CcSEcCtD
Pentoxifylline—PDE5A—epithelium—Crohn's disease	0.0124	0.0444	CbGeAlD
Pentoxifylline—Abdominal bloating—Mesalazine—Crohn's disease	0.0123	0.0254	CcSEcCtD
Pentoxifylline—PDE5A—smooth muscle tissue—Crohn's disease	0.012	0.0428	CbGeAlD
Pentoxifylline—ADORA2A—lymphoid tissue—Crohn's disease	0.0105	0.0376	CbGeAlD
Pentoxifylline—Cholecystitis—Mesalazine—Crohn's disease	0.0102	0.021	CcSEcCtD
Pentoxifylline—PDE5A—digestive system—Crohn's disease	0.00946	0.0338	CbGeAlD
Pentoxifylline—Cholestasis—Azathioprine—Crohn's disease	0.00847	0.0175	CcSEcCtD
Pentoxifylline—NT5E—lymph node—Crohn's disease	0.00832	0.0297	CbGeAlD
Pentoxifylline—Throat sore—Mesalazine—Crohn's disease	0.00813	0.0168	CcSEcCtD
Pentoxifylline—Oropharyngeal discomfort—Mesalazine—Crohn's disease	0.00806	0.0166	CcSEcCtD
Pentoxifylline—Cholestasis—Mesalazine—Crohn's disease	0.00772	0.0159	CcSEcCtD
Pentoxifylline—Scotoma—Mesalazine—Crohn's disease	0.00772	0.0159	CcSEcCtD
Pentoxifylline—PDE4B—mammalian vulva—Crohn's disease	0.00756	0.027	CbGeAlD
Pentoxifylline—PDE4B—lymphoid tissue—Crohn's disease	0.00671	0.024	CbGeAlD
Pentoxifylline—Oropharyngeal pain—Mesalazine—Crohn's disease	0.00645	0.0133	CcSEcCtD
Pentoxifylline—Pancytopenia—Mercaptopurine—Crohn's disease	0.00644	0.0133	CcSEcCtD
Pentoxifylline—PDE4A—lymph node—Crohn's disease	0.00635	0.0227	CbGeAlD
Pentoxifylline—Aplastic anaemia—Azathioprine—Crohn's disease	0.00604	0.0124	CcSEcCtD
Pentoxifylline—Eructation—Mesalazine—Crohn's disease	0.00576	0.0119	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00571	0.0118	CcSEcCtD
Pentoxifylline—Influenza like illness—Mesalazine—Crohn's disease	0.00569	0.0117	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Mesalazine—Crohn's disease	0.0055	0.0113	CcSEcCtD
Pentoxifylline—PDE5A—lymph node—Crohn's disease	0.0054	0.0193	CbGeAlD
Pentoxifylline—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00539	0.0111	CcSEcCtD
Pentoxifylline—ADORA1—lymph node—Crohn's disease	0.00512	0.0183	CbGeAlD
Pentoxifylline—Ear pain—Mesalazine—Crohn's disease	0.00499	0.0103	CcSEcCtD
Pentoxifylline—Immune system disorder—Mercaptopurine—Crohn's disease	0.0049	0.0101	CcSEcCtD
Pentoxifylline—Thirst—Mesalazine—Crohn's disease	0.00447	0.00921	CcSEcCtD
Pentoxifylline—Anaemia—Mercaptopurine—Crohn's disease	0.00436	0.00899	CcSEcCtD
Pentoxifylline—Leukopenia—Mercaptopurine—Crohn's disease	0.00423	0.00871	CcSEcCtD
Pentoxifylline—CYP1A2—digestive system—Crohn's disease	0.00407	0.0146	CbGeAlD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00399	0.00822	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Azathioprine—Crohn's disease	0.00387	0.00797	CcSEcCtD
Pentoxifylline—Oedema—Mercaptopurine—Crohn's disease	0.00385	0.00794	CcSEcCtD
Pentoxifylline—Pancytopenia—Azathioprine—Crohn's disease	0.00383	0.0079	CcSEcCtD
Pentoxifylline—PDE4B—lymph node—Crohn's disease	0.00379	0.0135	CbGeAlD
Pentoxifylline—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00377	0.00777	CcSEcCtD
Pentoxifylline—Skin disorder—Mercaptopurine—Crohn's disease	0.00374	0.00771	CcSEcCtD
Pentoxifylline—Abdominal distension—Mesalazine—Crohn's disease	0.0037	0.00763	CcSEcCtD
Pentoxifylline—Anorexia—Mercaptopurine—Crohn's disease	0.00367	0.00757	CcSEcCtD
Pentoxifylline—Bronchospasm—Mesalazine—Crohn's disease	0.00362	0.00745	CcSEcCtD
Pentoxifylline—Infestation NOS—Azathioprine—Crohn's disease	0.0036	0.00742	CcSEcCtD
Pentoxifylline—Infestation—Azathioprine—Crohn's disease	0.0036	0.00742	CcSEcCtD
Pentoxifylline—Angina pectoris—Mesalazine—Crohn's disease	0.00358	0.00738	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Mesalazine—Crohn's disease	0.00353	0.00726	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00351	0.00723	CcSEcCtD
Pentoxifylline—Pancytopenia—Mesalazine—Crohn's disease	0.00349	0.0072	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Azathioprine—Crohn's disease	0.0034	0.00701	CcSEcCtD
Pentoxifylline—Decreased appetite—Mercaptopurine—Crohn's disease	0.00335	0.0069	CcSEcCtD
Pentoxifylline—Infestation NOS—Mesalazine—Crohn's disease	0.00328	0.00676	CcSEcCtD
Pentoxifylline—Infestation—Mesalazine—Crohn's disease	0.00328	0.00676	CcSEcCtD
Pentoxifylline—Haemoglobin—Azathioprine—Crohn's disease	0.00325	0.00669	CcSEcCtD
Pentoxifylline—Haemorrhage—Azathioprine—Crohn's disease	0.00323	0.00666	CcSEcCtD
Pentoxifylline—Jaundice—Mesalazine—Crohn's disease	0.0032	0.00659	CcSEcCtD
Pentoxifylline—Conjunctivitis—Mesalazine—Crohn's disease	0.00319	0.00657	CcSEcCtD
Pentoxifylline—Sweating—Mesalazine—Crohn's disease	0.00314	0.00648	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Mesalazine—Crohn's disease	0.0031	0.00639	CcSEcCtD
Pentoxifylline—Epistaxis—Mesalazine—Crohn's disease	0.00309	0.00637	CcSEcCtD
Pentoxifylline—Body temperature increased—Mercaptopurine—Crohn's disease	0.00305	0.00628	CcSEcCtD
Pentoxifylline—Haemoglobin—Mesalazine—Crohn's disease	0.00296	0.0061	CcSEcCtD
Pentoxifylline—Haemorrhage—Mesalazine—Crohn's disease	0.00294	0.00606	CcSEcCtD
Pentoxifylline—Hepatitis—Mesalazine—Crohn's disease	0.00294	0.00606	CcSEcCtD
Pentoxifylline—Immune system disorder—Azathioprine—Crohn's disease	0.00292	0.00601	CcSEcCtD
Pentoxifylline—Arrhythmia—Azathioprine—Crohn's disease	0.00289	0.00595	CcSEcCtD
Pentoxifylline—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00284	0.00585	CcSEcCtD
Pentoxifylline—Immune system disorder—Mesalazine—Crohn's disease	0.00266	0.00548	CcSEcCtD
Pentoxifylline—Diarrhoea—Mercaptopurine—Crohn's disease	0.00264	0.00543	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Azathioprine—Crohn's disease	0.00261	0.00538	CcSEcCtD
Pentoxifylline—Anaemia—Azathioprine—Crohn's disease	0.0026	0.00536	CcSEcCtD
Pentoxifylline—Erythema—Mesalazine—Crohn's disease	0.00256	0.00528	CcSEcCtD
Pentoxifylline—Malaise—Azathioprine—Crohn's disease	0.00254	0.00523	CcSEcCtD
Pentoxifylline—Flatulence—Mesalazine—Crohn's disease	0.00253	0.0052	CcSEcCtD
Pentoxifylline—Leukopenia—Azathioprine—Crohn's disease	0.00252	0.00519	CcSEcCtD
Pentoxifylline—Vascular purpura—Prednisone—Crohn's disease	0.00252	0.00518	CcSEcCtD
Pentoxifylline—Tension—Mesalazine—Crohn's disease	0.00251	0.00518	CcSEcCtD
Pentoxifylline—Dysgeusia—Mesalazine—Crohn's disease	0.00251	0.00517	CcSEcCtD
Pentoxifylline—Nervousness—Mesalazine—Crohn's disease	0.00249	0.00513	CcSEcCtD
Pentoxifylline—Back pain—Mesalazine—Crohn's disease	0.00248	0.00511	CcSEcCtD
Pentoxifylline—Muscle spasms—Mesalazine—Crohn's disease	0.00246	0.00508	CcSEcCtD
Pentoxifylline—Vomiting—Mercaptopurine—Crohn's disease	0.00245	0.00505	CcSEcCtD
Pentoxifylline—Rash—Mercaptopurine—Crohn's disease	0.00243	0.00501	CcSEcCtD
Pentoxifylline—Dermatitis—Mercaptopurine—Crohn's disease	0.00243	0.005	CcSEcCtD
Pentoxifylline—Vision blurred—Mesalazine—Crohn's disease	0.00242	0.00498	CcSEcCtD
Pentoxifylline—Tremor—Mesalazine—Crohn's disease	0.0024	0.00495	CcSEcCtD
Pentoxifylline—Myalgia—Azathioprine—Crohn's disease	0.0024	0.00493	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00238	0.0049	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Mesalazine—Crohn's disease	0.00238	0.0049	CcSEcCtD
Pentoxifylline—Anaemia—Mesalazine—Crohn's disease	0.00237	0.00488	CcSEcCtD
Pentoxifylline—Discomfort—Azathioprine—Crohn's disease	0.00237	0.00488	CcSEcCtD
Pentoxifylline—Angioedema—Mesalazine—Crohn's disease	0.00234	0.00482	CcSEcCtD
Pentoxifylline—Purpura—Prednisone—Crohn's disease	0.00234	0.00481	CcSEcCtD
Pentoxifylline—Malaise—Mesalazine—Crohn's disease	0.00231	0.00476	CcSEcCtD
Pentoxifylline—Leukopenia—Mesalazine—Crohn's disease	0.00229	0.00473	CcSEcCtD
Pentoxifylline—Nausea—Mercaptopurine—Crohn's disease	0.00229	0.00472	CcSEcCtD
Pentoxifylline—Infection—Azathioprine—Crohn's disease	0.00228	0.0047	CcSEcCtD
Pentoxifylline—Palpitations—Mesalazine—Crohn's disease	0.00226	0.00467	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Azathioprine—Crohn's disease	0.00225	0.00463	CcSEcCtD
Pentoxifylline—Skin disorder—Azathioprine—Crohn's disease	0.00223	0.00459	CcSEcCtD
Pentoxifylline—Hypertension—Mesalazine—Crohn's disease	0.00221	0.00456	CcSEcCtD
Pentoxifylline—Chest pain—Mesalazine—Crohn's disease	0.00218	0.00449	CcSEcCtD
Pentoxifylline—Myalgia—Mesalazine—Crohn's disease	0.00218	0.00449	CcSEcCtD
Pentoxifylline—Anxiety—Mesalazine—Crohn's disease	0.00217	0.00448	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00217	0.00446	CcSEcCtD
Pentoxifylline—Discomfort—Mesalazine—Crohn's disease	0.00216	0.00444	CcSEcCtD
Pentoxifylline—Hypotension—Azathioprine—Crohn's disease	0.00215	0.00442	CcSEcCtD
Pentoxifylline—Dry mouth—Mesalazine—Crohn's disease	0.00213	0.0044	CcSEcCtD
Pentoxifylline—Confusional state—Mesalazine—Crohn's disease	0.00211	0.00434	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00209	0.00431	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Mesalazine—Crohn's disease	0.00209	0.00431	CcSEcCtD
Pentoxifylline—Oedema—Mesalazine—Crohn's disease	0.00209	0.00431	CcSEcCtD
Pentoxifylline—Infection—Mesalazine—Crohn's disease	0.00208	0.00428	CcSEcCtD
Pentoxifylline—Shock—Mesalazine—Crohn's disease	0.00206	0.00424	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Mesalazine—Crohn's disease	0.00205	0.00422	CcSEcCtD
Pentoxifylline—Tachycardia—Mesalazine—Crohn's disease	0.00204	0.00421	CcSEcCtD
Pentoxifylline—Skin disorder—Mesalazine—Crohn's disease	0.00203	0.00419	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Mesalazine—Crohn's disease	0.00202	0.00417	CcSEcCtD
Pentoxifylline—Anorexia—Mesalazine—Crohn's disease	0.00199	0.00411	CcSEcCtD
Pentoxifylline—Abdominal distension—Prednisone—Crohn's disease	0.00196	0.00404	CcSEcCtD
Pentoxifylline—Hypotension—Mesalazine—Crohn's disease	0.00195	0.00403	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00191	0.00393	CcSEcCtD
Pentoxifylline—Feeling abnormal—Azathioprine—Crohn's disease	0.00189	0.0039	CcSEcCtD
Pentoxifylline—Insomnia—Mesalazine—Crohn's disease	0.00189	0.0039	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00188	0.00387	CcSEcCtD
Pentoxifylline—Dyspnoea—Mesalazine—Crohn's disease	0.00186	0.00384	CcSEcCtD
Pentoxifylline—Somnolence—Mesalazine—Crohn's disease	0.00186	0.00383	CcSEcCtD
Pentoxifylline—Dyspepsia—Mesalazine—Crohn's disease	0.00184	0.00379	CcSEcCtD
Pentoxifylline—Decreased appetite—Mesalazine—Crohn's disease	0.00182	0.00375	CcSEcCtD
Pentoxifylline—Abdominal pain—Azathioprine—Crohn's disease	0.00182	0.00374	CcSEcCtD
Pentoxifylline—Body temperature increased—Azathioprine—Crohn's disease	0.00182	0.00374	CcSEcCtD
Pentoxifylline—Constipation—Mesalazine—Crohn's disease	0.00179	0.00368	CcSEcCtD
Pentoxifylline—Feeling abnormal—Mesalazine—Crohn's disease	0.00172	0.00355	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00171	0.00352	CcSEcCtD
Pentoxifylline—Hypersensitivity—Azathioprine—Crohn's disease	0.00169	0.00349	CcSEcCtD
Pentoxifylline—Urticaria—Mesalazine—Crohn's disease	0.00166	0.00342	CcSEcCtD
Pentoxifylline—Abdominal pain—Mesalazine—Crohn's disease	0.00165	0.00341	CcSEcCtD
Pentoxifylline—Body temperature increased—Mesalazine—Crohn's disease	0.00165	0.00341	CcSEcCtD
Pentoxifylline—Diarrhoea—Azathioprine—Crohn's disease	0.00157	0.00324	CcSEcCtD
Pentoxifylline—Haemoglobin—Prednisone—Crohn's disease	0.00157	0.00323	CcSEcCtD
Pentoxifylline—Haemorrhage—Prednisone—Crohn's disease	0.00156	0.00321	CcSEcCtD
Pentoxifylline—Hypersensitivity—Mesalazine—Crohn's disease	0.00154	0.00317	CcSEcCtD
Pentoxifylline—Dizziness—Azathioprine—Crohn's disease	0.00152	0.00313	CcSEcCtD
Pentoxifylline—Asthenia—Mesalazine—Crohn's disease	0.0015	0.00309	CcSEcCtD
Pentoxifylline—Pruritus—Mesalazine—Crohn's disease	0.00148	0.00305	CcSEcCtD
Pentoxifylline—Vomiting—Azathioprine—Crohn's disease	0.00146	0.00301	CcSEcCtD
Pentoxifylline—Rash—Azathioprine—Crohn's disease	0.00145	0.00298	CcSEcCtD
Pentoxifylline—Dermatitis—Azathioprine—Crohn's disease	0.00145	0.00298	CcSEcCtD
Pentoxifylline—Flushing—Prednisone—Crohn's disease	0.00145	0.00298	CcSEcCtD
Pentoxifylline—Headache—Azathioprine—Crohn's disease	0.00144	0.00296	CcSEcCtD
Pentoxifylline—Diarrhoea—Mesalazine—Crohn's disease	0.00143	0.00295	CcSEcCtD
Pentoxifylline—Immune system disorder—Prednisone—Crohn's disease	0.00141	0.0029	CcSEcCtD
Pentoxifylline—Arrhythmia—Prednisone—Crohn's disease	0.00139	0.00287	CcSEcCtD
Pentoxifylline—Dizziness—Mesalazine—Crohn's disease	0.00138	0.00285	CcSEcCtD
Pentoxifylline—Nausea—Azathioprine—Crohn's disease	0.00136	0.00281	CcSEcCtD
Pentoxifylline—Erythema—Prednisone—Crohn's disease	0.00136	0.00279	CcSEcCtD
Pentoxifylline—Vomiting—Mesalazine—Crohn's disease	0.00133	0.00274	CcSEcCtD
Pentoxifylline—Rash—Mesalazine—Crohn's disease	0.00132	0.00272	CcSEcCtD
Pentoxifylline—Dermatitis—Mesalazine—Crohn's disease	0.00132	0.00271	CcSEcCtD
Pentoxifylline—Headache—Mesalazine—Crohn's disease	0.00131	0.0027	CcSEcCtD
Pentoxifylline—Vision blurred—Prednisone—Crohn's disease	0.00128	0.00263	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Prednisone—Crohn's disease	0.00126	0.00259	CcSEcCtD
Pentoxifylline—Anaemia—Prednisone—Crohn's disease	0.00125	0.00258	CcSEcCtD
Pentoxifylline—Agitation—Prednisone—Crohn's disease	0.00125	0.00257	CcSEcCtD
Pentoxifylline—Nausea—Mesalazine—Crohn's disease	0.00124	0.00256	CcSEcCtD
Pentoxifylline—Angioedema—Prednisone—Crohn's disease	0.00124	0.00255	CcSEcCtD
Pentoxifylline—Malaise—Prednisone—Crohn's disease	0.00122	0.00252	CcSEcCtD
Pentoxifylline—Convulsion—Prednisone—Crohn's disease	0.00117	0.00242	CcSEcCtD
Pentoxifylline—Hypertension—Prednisone—Crohn's disease	0.00117	0.00241	CcSEcCtD
Pentoxifylline—Myalgia—Prednisone—Crohn's disease	0.00115	0.00238	CcSEcCtD
Pentoxifylline—Anxiety—Prednisone—Crohn's disease	0.00115	0.00237	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00115	0.00236	CcSEcCtD
Pentoxifylline—Discomfort—Prednisone—Crohn's disease	0.00114	0.00235	CcSEcCtD
Pentoxifylline—Oedema—Prednisone—Crohn's disease	0.00111	0.00228	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisone—Crohn's disease	0.00111	0.00228	CcSEcCtD
Pentoxifylline—Infection—Prednisone—Crohn's disease	0.0011	0.00226	CcSEcCtD
Pentoxifylline—Shock—Prednisone—Crohn's disease	0.00109	0.00224	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisone—Crohn's disease	0.00108	0.00222	CcSEcCtD
Pentoxifylline—Skin disorder—Prednisone—Crohn's disease	0.00107	0.00221	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisone—Crohn's disease	0.00107	0.0022	CcSEcCtD
Pentoxifylline—Anorexia—Prednisone—Crohn's disease	0.00105	0.00217	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00101	0.00208	CcSEcCtD
Pentoxifylline—Insomnia—Prednisone—Crohn's disease	0.001	0.00206	CcSEcCtD
Pentoxifylline—Dyspepsia—Prednisone—Crohn's disease	0.000974	0.00201	CcSEcCtD
Pentoxifylline—Decreased appetite—Prednisone—Crohn's disease	0.000962	0.00198	CcSEcCtD
Pentoxifylline—Constipation—Prednisone—Crohn's disease	0.000946	0.00195	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisone—Crohn's disease	0.000912	0.00188	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Prednisone—Crohn's disease	0.000905	0.00186	CcSEcCtD
Pentoxifylline—Urticaria—Prednisone—Crohn's disease	0.000879	0.00181	CcSEcCtD
Pentoxifylline—Abdominal pain—Prednisone—Crohn's disease	0.000875	0.0018	CcSEcCtD
Pentoxifylline—Body temperature increased—Prednisone—Crohn's disease	0.000875	0.0018	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisone—Crohn's disease	0.000815	0.00168	CcSEcCtD
Pentoxifylline—Asthenia—Prednisone—Crohn's disease	0.000794	0.00164	CcSEcCtD
Pentoxifylline—Pruritus—Prednisone—Crohn's disease	0.000783	0.00161	CcSEcCtD
Pentoxifylline—Diarrhoea—Prednisone—Crohn's disease	0.000757	0.00156	CcSEcCtD
Pentoxifylline—Dizziness—Prednisone—Crohn's disease	0.000732	0.00151	CcSEcCtD
Pentoxifylline—Vomiting—Prednisone—Crohn's disease	0.000704	0.00145	CcSEcCtD
Pentoxifylline—Rash—Prednisone—Crohn's disease	0.000698	0.00144	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisone—Crohn's disease	0.000697	0.00144	CcSEcCtD
Pentoxifylline—Headache—Prednisone—Crohn's disease	0.000693	0.00143	CcSEcCtD
Pentoxifylline—PDE4B—GPCR downstream signaling—CCR9—Crohn's disease	0.00069	0.00294	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—RIPK2—Crohn's disease	0.000686	0.00292	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—IL2RA—Crohn's disease	0.000678	0.00289	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCR9—Crohn's disease	0.000677	0.00288	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ACKR2—Crohn's disease	0.00067	0.00285	CbGpPWpGaD
Pentoxifylline—Nausea—Prednisone—Crohn's disease	0.000657	0.00135	CcSEcCtD
Pentoxifylline—ADORA1—GPCR downstream signaling—GPR65—Crohn's disease	0.000649	0.00276	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—GPR65—Crohn's disease	0.000641	0.00273	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MLN—Crohn's disease	0.000635	0.00271	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCR9—Crohn's disease	0.000634	0.0027	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CCR6—Crohn's disease	0.000632	0.00269	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—GPR65—Crohn's disease	0.000629	0.00268	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCR9—Crohn's disease	0.000626	0.00267	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ACKR2—Crohn's disease	0.000609	0.00259	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—GPR65—Crohn's disease	0.000589	0.00251	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—GPR65—Crohn's disease	0.000582	0.00248	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TAGAP—Crohn's disease	0.000581	0.00248	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MLN—Crohn's disease	0.000577	0.00246	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL1B—Crohn's disease	0.000576	0.00245	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ACKR2—Crohn's disease	0.00057	0.00243	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ACKR2—Crohn's disease	0.000563	0.0024	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—PTGER4—Crohn's disease	0.000556	0.00237	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CCR6—Crohn's disease	0.000544	0.00232	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MLN—Crohn's disease	0.00054	0.0023	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCR9—Crohn's disease	0.000539	0.0023	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MLN—Crohn's disease	0.000534	0.00227	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TAGAP—Crohn's disease	0.000528	0.00225	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RSPO3—Crohn's disease	0.000508	0.00216	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—GPR65—Crohn's disease	0.000501	0.00213	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TAGAP—Crohn's disease	0.000494	0.0021	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCR6—Crohn's disease	0.000494	0.0021	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CCR6—Crohn's disease	0.000494	0.0021	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—ALB—Crohn's disease	0.00049	0.00209	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCR9—Crohn's disease	0.000489	0.00208	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TAGAP—Crohn's disease	0.000488	0.00208	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SEL1L—Crohn's disease	0.000482	0.00205	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PTGER4—Crohn's disease	0.000479	0.00204	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CCR6—Crohn's disease	0.000462	0.00197	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RSPO3—Crohn's disease	0.000461	0.00196	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CCR6—Crohn's disease	0.000457	0.00195	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—JAK2—Crohn's disease	0.000455	0.00194	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—GPR65—Crohn's disease	0.000455	0.00194	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000453	0.00193	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCR6—Crohn's disease	0.000448	0.00191	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCR9—Crohn's disease	0.00044	0.00188	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ACKR2—Crohn's disease	0.00044	0.00187	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SEL1L—Crohn's disease	0.000437	0.00186	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000436	0.00185	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PTGER4—Crohn's disease	0.000435	0.00185	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000435	0.00185	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RSPO3—Crohn's disease	0.000432	0.00184	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—TYK2—Crohn's disease	0.000429	0.00183	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RSPO3—Crohn's disease	0.000427	0.00182	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCR6—Crohn's disease	0.00042	0.00179	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MLN—Crohn's disease	0.000417	0.00178	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCR6—Crohn's disease	0.000415	0.00177	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GPR65—Crohn's disease	0.000409	0.00174	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SEL1L—Crohn's disease	0.000409	0.00174	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—JAK2—Crohn's disease	0.000409	0.00174	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL3—Crohn's disease	0.000408	0.00174	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000407	0.00173	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000407	0.00173	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SEL1L—Crohn's disease	0.000405	0.00172	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PTGER4—Crohn's disease	0.000402	0.00171	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCR9—Crohn's disease	0.0004	0.0017	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PTGER4—Crohn's disease	0.000395	0.00168	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000394	0.00168	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TAGAP—Crohn's disease	0.000382	0.00162	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCR9—Crohn's disease	0.000374	0.00159	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GPR65—Crohn's disease	0.000372	0.00158	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL3—Crohn's disease	0.00037	0.00158	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL3—Crohn's disease	0.00037	0.00158	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCR9—Crohn's disease	0.00037	0.00158	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.00037	0.00158	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PTGER4—Crohn's disease	0.00037	0.00157	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PTGER4—Crohn's disease	0.000365	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—RASGRP1—Crohn's disease	0.000358	0.00153	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000358	0.00153	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCR6—Crohn's disease	0.000357	0.00152	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000355	0.00151	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GPR65—Crohn's disease	0.000348	0.00148	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL3—Crohn's disease	0.000347	0.00148	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000346	0.00147	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GPR65—Crohn's disease	0.000344	0.00147	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL3—Crohn's disease	0.000343	0.00146	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—Crohn's disease	0.000337	0.00144	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL3—Crohn's disease	0.000336	0.00143	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000335	0.00143	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RSPO3—Crohn's disease	0.000333	0.00142	CbGpPWpGaD
Pentoxifylline—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000332	0.00141	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000331	0.00141	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.00033	0.00141	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—TYK2—Crohn's disease	0.00033	0.00141	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000325	0.00139	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCR6—Crohn's disease	0.000324	0.00138	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SEL1L—Crohn's disease	0.000316	0.00135	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL3—Crohn's disease	0.000315	0.00134	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—JAK2—Crohn's disease	0.000315	0.00134	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000314	0.00134	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL3—Crohn's disease	0.000311	0.00133	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—CXCL8—Crohn's disease	0.00031	0.00132	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000305	0.0013	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—RASGRP1—Crohn's disease	0.000301	0.00128	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	0.0003	0.00128	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCR6—Crohn's disease	0.000292	0.00124	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR9—Crohn's disease	0.000289	0.00123	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000286	0.00122	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PTGER4—Crohn's disease	0.000285	0.00122	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000284	0.00121	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—IL6—Crohn's disease	0.000277	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GPR65—Crohn's disease	0.000269	0.00114	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL3—Crohn's disease	0.000268	0.00114	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000267	0.00114	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCR6—Crohn's disease	0.000265	0.00113	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RBX1—Crohn's disease	0.000264	0.00112	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CXCL8—Crohn's disease	0.000264	0.00112	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ALB—Crohn's disease	0.000262	0.00112	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2RA—Crohn's disease	0.000259	0.0011	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000259	0.0011	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000259	0.0011	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTGER4—Crohn's disease	0.000257	0.00109	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCR6—Crohn's disease	0.000248	0.00106	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCR6—Crohn's disease	0.000245	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL3—Crohn's disease	0.000243	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000243	0.00103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000242	0.00103	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2RA—Crohn's disease	0.00024	0.00102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RBX1—Crohn's disease	0.00024	0.00102	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.00024	0.00102	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.00024	0.00102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2RA—Crohn's disease	0.000236	0.001	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000235	0.001	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTGER4—Crohn's disease	0.000233	0.000993	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—UBE2D1—Crohn's disease	0.000231	0.000985	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—STAT3—Crohn's disease	0.000231	0.000984	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PTGS2—Crohn's disease	0.000229	0.000976	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RIPK2—Crohn's disease	0.000224	0.000956	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RBX1—Crohn's disease	0.000224	0.000956	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RBX1—Crohn's disease	0.000222	0.000944	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2RA—Crohn's disease	0.000221	0.00094	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL3—Crohn's disease	0.000219	0.000932	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTGER4—Crohn's disease	0.000218	0.00093	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2RA—Crohn's disease	0.000218	0.000928	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTGER4—Crohn's disease	0.000216	0.000919	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—IL6—Crohn's disease	0.000214	0.000912	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RASGRP1—Crohn's disease	0.000212	0.000901	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—UBE2D1—Crohn's disease	0.00021	0.000895	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	0.00021	0.000894	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RIPK2—Crohn's disease	0.000204	0.000868	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CXCL8—Crohn's disease	0.000204	0.000867	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL3—Crohn's disease	0.000199	0.000846	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—UBE2D1—Crohn's disease	0.000197	0.000838	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—UBE2D1—Crohn's disease	0.000194	0.000828	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RASGRP1—Crohn's disease	0.000192	0.000818	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—JAK2—Crohn's disease	0.000192	0.000818	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SOCS1—Crohn's disease	0.000192	0.000816	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR6—Crohn's disease	0.000192	0.000816	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RIPK2—Crohn's disease	0.000191	0.000812	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RIPK2—Crohn's disease	0.000188	0.000803	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000188	0.000802	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000188	0.000799	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL3—Crohn's disease	0.000186	0.000792	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL3—Crohn's disease	0.000184	0.000783	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TYK2—Crohn's disease	0.000183	0.000779	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RASGRP1—Crohn's disease	0.00018	0.000766	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RASGRP1—Crohn's disease	0.000178	0.000757	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000176	0.000751	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000175	0.000746	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—JAK2—Crohn's disease	0.000174	0.000743	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—JAK2—Crohn's disease	0.000174	0.000743	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SOCS1—Crohn's disease	0.000174	0.000741	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RBX1—Crohn's disease	0.000173	0.000738	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2RA—Crohn's disease	0.00017	0.000725	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTGER4—Crohn's disease	0.000169	0.000718	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TYK2—Crohn's disease	0.000166	0.000707	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SMAD3—Crohn's disease	0.000166	0.000705	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—JAK2—Crohn's disease	0.000163	0.000695	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SOCS1—Crohn's disease	0.000163	0.000694	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—Crohn's disease	0.000161	0.000688	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—JAK2—Crohn's disease	0.000161	0.000687	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SOCS1—Crohn's disease	0.000161	0.000686	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCL8—Crohn's disease	0.000159	0.000678	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000159	0.000678	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—JAK2—Crohn's disease	0.000158	0.000674	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TYK2—Crohn's disease	0.000155	0.000662	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TYK2—Crohn's disease	0.000154	0.000654	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2RA—Crohn's disease	0.000153	0.000653	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000152	0.000647	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SMAD3—Crohn's disease	0.00015	0.00064	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000149	0.000635	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—JAK2—Crohn's disease	0.000148	0.000631	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RIPK2—Crohn's disease	0.000147	0.000627	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000147	0.000627	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—JAK2—Crohn's disease	0.000147	0.000624	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCL8—Crohn's disease	0.000145	0.000615	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL3—Crohn's disease	0.000144	0.000612	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SMAD3—Crohn's disease	0.000141	0.000599	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2RA—Crohn's disease	0.000139	0.000593	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SMAD3—Crohn's disease	0.000139	0.000592	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000139	0.000592	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL8—Crohn's disease	0.000135	0.000576	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL8—Crohn's disease	0.000134	0.00057	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2RA—Crohn's disease	0.00013	0.000555	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2RA—Crohn's disease	0.000129	0.000548	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	0.000127	0.000539	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—JAK2—Crohn's disease	0.000126	0.000537	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SOCS1—Crohn's disease	0.000126	0.000536	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TYK2—Crohn's disease	0.00012	0.000511	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000115	0.00049	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—JAK2—Crohn's disease	0.000114	0.000488	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SMAD3—Crohn's disease	0.000109	0.000463	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TYK2—Crohn's disease	0.000108	0.00046	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTMR3—Crohn's disease	0.000108	0.000459	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL8—Crohn's disease	0.000104	0.000445	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—JAK2—Crohn's disease	0.000103	0.000439	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2RA—Crohn's disease	0.000101	0.000429	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TYK2—Crohn's disease	9.81e-05	0.000418	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL8—Crohn's disease	9.4e-05	0.0004	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JAK2—Crohn's disease	9.35e-05	0.000398	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TYK2—Crohn's disease	9.18e-05	0.000391	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TYK2—Crohn's disease	9.07e-05	0.000386	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—Crohn's disease	8.94e-05	0.000381	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JAK2—Crohn's disease	8.76e-05	0.000373	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JAK2—Crohn's disease	8.66e-05	0.000369	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL8—Crohn's disease	8.54e-05	0.000364	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—FADS1—Crohn's disease	8.39e-05	0.000357	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—Crohn's disease	8.12e-05	0.000346	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL8—Crohn's disease	7.99e-05	0.00034	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL8—Crohn's disease	7.9e-05	0.000336	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GPX4—Crohn's disease	7.86e-05	0.000335	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—Crohn's disease	7.6e-05	0.000324	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GCKR—Crohn's disease	7.59e-05	0.000323	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—Crohn's disease	7.56e-05	0.000322	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—Crohn's disease	7.51e-05	0.00032	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TYK2—Crohn's disease	7.09e-05	0.000302	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—Crohn's disease	6.87e-05	0.000292	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JAK2—Crohn's disease	6.76e-05	0.000288	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—Crohn's disease	6.43e-05	0.000274	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—Crohn's disease	6.35e-05	0.000271	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL8—Crohn's disease	6.17e-05	0.000263	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—Crohn's disease	5.87e-05	0.00025	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.42e-05	0.000231	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—Crohn's disease	5.28e-05	0.000225	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—Crohn's disease	4.96e-05	0.000211	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—Crohn's disease	4.8e-05	0.000204	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.74e-05	0.000202	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—Crohn's disease	4.49e-05	0.000191	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—Crohn's disease	4.44e-05	0.000189	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—Crohn's disease	3.47e-05	0.000148	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALB—Crohn's disease	2.41e-05	0.000103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.11e-05	9e-05	CbGpPWpGaD
